Specific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell-mediated tumor regression

Fri, 08/02/2019 - 12:00

J Exp Med

Accession number

31375534

Volume

pii: jem.20182124

Authors short

Etzerodt A.

Authors

Etzerodt A, Tsalkitzi K, Maniecki M, Damsky W, Delfini M, Baudoin E, Moulin M, Bosenberg M, Graversen JH, Auphan-Anezin N, Moestrup SK, Lawrence T.

URL

https://www.ncbi.nlm.nih.gov/pubmed/31375534